adaptive biotechnologies stock analysis
ADPT Stock Price Prediction 1350 11565 Upside Based on 4 Wall Street analysts offering 12 month price targets for Adaptive Biotechnologies in the last 3 months. Why Adaptive Biotechnologies and Smartsheet will be mega-cap stocks in the future.
Adaptive Biotechnologies Corporation Stock Value Analysis Nyse Adpt
Stock Price Forecast According to 15 stock analysts the average 12-month stock price forecast for ADPT stock is 1343 which predicts an increase of 8783.
. Stay up to date on the latest stock price chart news analysis fundamentals trading and. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. View More ADPT Articles Market-beating stocks from our award-winning analyst team.
Adaptive Biotechnologies Corporation has a market cap of 121 billion and is expected to release its quarterly earnings report on Feb 22 2022 Feb 28 2022. Adaptive Biotechnologies ADPT. Detailed financial statements for Adaptive Biotechnologies ADPT including the income statement balance sheet and cash flow statement.
A high-level overview of Adaptive Biotechnologies Corporation ADPT stock. ADPT Adaptive Biotechnologies Stock Price Analysis 573 Followers ADPT Stock Chart Stats Advanced Chart Days Range 0 - 0 52-Week Range 596 - 3755 Previous Close 712. Shares of ADPT stock opened at 747 on Thursday.
ADPT Stock Overview Adaptive Biotechnologies Corporation a commercial-stage company develops an immune medicine platform for the diagnosis and treatment of various diseases. See Adaptive Biotechnologies Corporation ADPT stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Its immune medicine platform combines a.
ADPT Adaptive Biotechnologies - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. The company has a 50 day moving average price of 803 and a 200-day moving average price of 864. As of the 3rd of April Adaptive Biotechnologies shows the risk adjusted performance of 013 and Mean Deviation of 435Adaptive Biotechnologies technical analysis gives you the.
Create real-time notifications to follow any changes in the live stock price. Adaptive Biotechnologies Stock analysis including Adaptive Biotechnologies investment evaluation stock information alerts predictive tools such as market volatility and liquidity. View todays Adaptive Biotechnologies Corp stock price and latest ADPT news and analysis.
Find the latest Adaptive Biotechnologies Corporation 1HMMU stock quote history news and other vital information to help you with your stock trading and investing. Detailed balance sheet for Adaptive Biotechnologies ADPT including cash debt assets liabilities and book value.
Adpt Adaptive Biotechnologies Corp Stock Overview U S Nasdaq Barron S
As Adaptive Biotechnologies Corporation S Nasdaq Adpt Market Cap Dropped By Us 51m Insiders Who Sold Us 514k Worth Of Stock Were Able To Offset Their Losses Simply Wall St News
7 Crashing Stocks You Might Want To Collect Kiplinger
Forecast Of The U S Copper Demand A Framework Based On Scenario Analysis And Stock Dynamics Environmental Science Technology
Heterogeneity And Clonal Relationships Of Adaptive Immune Cells In Ulcerative Colitis Revealed By Single Cell Analyses Science Immunology
Stock Market Shrinkage Exacerbated By Europe Ipos At Decade Low Bnn Bloomberg
Adaptive Biotechnologies Corporation Adpt Stock Price Quote News Stock Analysis
Full Article Unraveling S P500 Stock Volatility And Networks An Encoding And Decoding Approach
Microsoft Is Cashing In On Ipo Of Adaptive Biotechnologies
Big Debut Shares Of Adaptive Biotechnologies Rise 100 On First Day As Public Company Geekwire
Adpt Candlestick Chart Analysis Of Adaptive Biotechnologies Corporation
Data Free Full Text A Hybrid Stock Price Prediction Model Based On Pre And Deep Neural Network Html
Adaptive Biotechnologies Stock Isn T Cheap Nasdaq Adpt Seeking Alpha
Adaptive Biotechnologies A Platform Play For Immune Driven Medicine Nasdaq Adpt Seeking Alpha
Goldman Sachs These 2 Stocks Are Poised To Surge By At Least 30 Nasdaq
Ark Invest Analyst Breaks Down Adaptive Biotechnologies And Invitae
Microsoft Is Cashing In On Ipo Of Adaptive Biotechnologies
Adpt 10k 20201231 Htm
One Of Avalara S Earliest And Largest Investors Opposes Sale Of Company To Vista Equity Partners